Validation of different personalized risk models of chemotherapy‐induced nausea and vomiting: results of a randomized, double‐blind, phase III trial of fosaprepitant for cancer patients treated with high‐dose cisplatin.
| Autor: | Zhao, Yuanyuan, Zhao, Bing, Chen, Gang, Chen, Yinlan, Liao, Zijun, Zhang, Haiming, Feng, Weineng, Li, Yinyin, Weng, Heng, Li, Weidong, Zhou, Yuefen, Ren, Biyong, Lu, Yanda, Chen, Jianhua, Liu, Zhenteng, Su, Zhenzhong, Wang, Wenliang, Zhang, Li |
|---|---|
| Zdroj: | Cancer Communications; Feb2023, Vol. 43 Issue 2, p246-256, 11p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|
Plný text